David Dankort
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Journal: The Journal of clinical investigation
Published: May 01, 2024
Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.
Journal: Cancer research
Published: June 12, 2023
MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway.
Journal: Molecular cancer research : MCR
Published: October 04, 2021
Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence.
Journal: Molecular cancer research : MCR
Published: October 12, 2020
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Journal: The Journal of clinical investigation
Published: May 28, 2020
p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer.
Journal: Oncogene
Published: January 17, 2017
Construction of Modular Lentiviral Vectors for Effective Gene Expression and Knockdown.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 19, 2016
Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720.
Journal: Molecular cancer research : MCR
Published: October 25, 2013
Ras effector mutant expression suggest a negative regulator inhibits lung tumor formation.
Journal: PloS one
Published: September 11, 2013
RAS transformation requires CUX1-dependent repair of oxidative DNA damage.
Journal: PLoS biology
Published: August 19, 2013
Last Updated: 09/26/2026